Mycorena Acquired by Biomass Fermentation Firm Naplasol, Member of Animal Protein VEOS Group

Mycorena, a pioneering mycoprotein company, recently faced financial challenges and filed for bankruptcy earlier this year. However, they have now been acquired by Naplasol, a biomass fermentation firm and a member of the Animal Protein VEOS Group. This acquisition allows Naplasol to enhance its portfolio by producing Mycorena's flagship product, Promyc, at its industrial facility in Belgium. The VEOS Group, a global leader in the animal protein market, sees potential in mycoproteins as a sustainable protein alternative with a lower environmental footprint.

Despite Mycorena's struggles, the acquisition by Naplasol presents an opportunity to continue building on the company's innovations and market presence. Both companies see synergies in their complementary knowledge and products, with a shared belief in the future of mycoproteins. The founders of Mycorena express excitement for the future of the company under the industrial expertise of the VEOS Group, aiming to further develop and thrive in the mycoprotein industry.